全文获取类型
收费全文 | 255篇 |
免费 | 20篇 |
国内免费 | 27篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 19篇 |
妇产科学 | 3篇 |
基础医学 | 32篇 |
口腔科学 | 18篇 |
临床医学 | 45篇 |
内科学 | 64篇 |
皮肤病学 | 8篇 |
神经病学 | 3篇 |
特种医学 | 25篇 |
外科学 | 20篇 |
综合类 | 18篇 |
预防医学 | 15篇 |
药学 | 15篇 |
中国医学 | 1篇 |
肿瘤学 | 15篇 |
出版年
2022年 | 2篇 |
2021年 | 1篇 |
2020年 | 3篇 |
2019年 | 3篇 |
2018年 | 5篇 |
2017年 | 6篇 |
2016年 | 7篇 |
2015年 | 5篇 |
2014年 | 6篇 |
2013年 | 12篇 |
2012年 | 3篇 |
2011年 | 3篇 |
2010年 | 10篇 |
2009年 | 10篇 |
2008年 | 5篇 |
2007年 | 12篇 |
2006年 | 9篇 |
2005年 | 15篇 |
2004年 | 5篇 |
2003年 | 4篇 |
2002年 | 7篇 |
2001年 | 11篇 |
2000年 | 4篇 |
1999年 | 9篇 |
1998年 | 21篇 |
1997年 | 18篇 |
1996年 | 17篇 |
1995年 | 13篇 |
1994年 | 14篇 |
1993年 | 4篇 |
1992年 | 3篇 |
1991年 | 3篇 |
1990年 | 3篇 |
1989年 | 7篇 |
1988年 | 5篇 |
1987年 | 5篇 |
1986年 | 10篇 |
1985年 | 4篇 |
1982年 | 2篇 |
1981年 | 2篇 |
1980年 | 1篇 |
1978年 | 3篇 |
1977年 | 3篇 |
1976年 | 4篇 |
1975年 | 3篇 |
排序方式: 共有302条查询结果,搜索用时 0 毫秒
301.
High-yield platelet concentrates attainable by continuous quality improvement reduce platelet transfusion cost and donor exposure 总被引:1,自引:0,他引:1
DL Kelley ; RL Fegan ; AT Ng ; MK Kennedy ; E Blanda ; LA Chambers ; MS Kennedy ; LC Lasky 《Transfusion》1997,37(5):482-486
BACKGROUND: Donor exposure risk and cost in platelet transfusion practice can be limited by increasing the recovery of platelets from donor units. STUDY DESIGN AND METHODS: This study presents results of continuous quality improvement efforts in platelet production and compares the in vivo therapeutic efficacy of currently produced platelet concentrates (PCs) with that of apheresis platelets. Production quality improvement measures included optimization of instrument performance (rotor speed trials), process (massaging whole- blood units, using cup liners, limiting spin-expression time, and refining plasma expression technique), and staff (intensive training with observation and ongoing quality control data feedback). Corrected count increments and increments per kg were calculated for transfusions of 4 pooled PCs and apheresis platelets over a 30-day period. RESULTS: The mean number of platelets per PC increased from 5.5 × 10(10) in 1975 to 9.69 × 10(10) in 1994. The mean platelet dose was 3.78 × 10(11) for 4 PCs and 4.17 × 10(11) for apheresis platelets. A total of 34 pooled PCs and 17 apheresis platelets was transfused to 21 patients. The mean increment, the increment per kg, and the corrected count increment were, respectively, 31 × 10(3) per microL, 4.8 × 10(2) per microL, and 14,700 for 4 PCs and 35.4 × 10(3) per microL, 5.4 × 10(2) per microL, and 14,700 for apheresis platelets. Differences were not significant. CONCLUSION: Therapeutic efficacy comparable to that of apheresis platelets can be obtained with 4 high-yield PCs. 相似文献
302.
Blazar BR; Kersey JH; McGlave PB; Vallera DA; Lasky LC; Haake RJ; Bostrom B; Weisdorf DR; Epstein C; Ramsay NK 《Blood》1989,73(3):849-857
Based on the recent reports that recombinant human granulocyte/macrophage colony-stimulating factor (rhGM-CSF) accelerates the rate of engraftment in a variety of autologous bone marrow transplantation settings, we have investigated its effects on hematopoietic recovery of patients with acute lymphoblastic leukemia (ALL) undergoing autologous bone marrow transplantation. Our studies, which involved 25 autologous ALL recipients who received rhGM-CSF and 27 controls similar for disease status (remission or relapse) and disease type (B- or T-lineage) differed from previous studies in one important aspect: the bone marrows were purged with 4- hydroperoxcyclophosphamide (4HC) and anti-T or anti-B-cell lineage- specific antibodies before transplantation. Such treatments frequently lead to a reduction in the CFU-GM content of the transplanted marrow. Eighteen of 25 patients completed the entire course of rhGM-CSF. Of the 16 patients who received greater than or equal to 64 micrograms/M2/d for at least eight days, there were five patients who had an apparent rhGM-CSF response and 11 patients who did not respond. Of the parameters analyzed, only the number of CFU-GM progenitor cells infused per kilogram was significantly associated with an rhGM-CSF response. All patients receiving greater than or equal to 1.2 x 10(4) CFU-GM progenitors per kilogram achieved an absolute neutrophil count (ANC) greater than or equal to 1,000/microL by day 21 and had a greater than 50% decrement in ANC within 48 to 72 hours of discontinuing rhGM-CSF, as contrasted to none of the patients receiving less than or equal to 7.2 x 10(3) CFU-GM progenitors per kilogram.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献